Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Haleon US Holdings LLC

US Class III Ongoing · initiated 2025-12-26

Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for missing or illegible lot and expiration date coding on the bottles.

ERYTHROMYCIN OPHTHALMIC OINTMENT USP

Canada Type II Ongoing · initiated 2025-12-23

Product quality. Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health c…

Cipla USA, Inc.

US Class III Ongoing · initiated 2025-12-22

Failed PH Specifications

Baxter Healthcare Corporation

US Class II Ongoing · initiated 2025-12-22

Presence of particulate matter: plastic particles from the bottle rim were observed floating into the solution

HANDELNINE GLOBAL LLC

US Class I Ongoing · initiated 2025-12-22

CGMP Deviations: product found to contain lead.

Zydus Pharmaceuticals (USA) Inc

US Class III Ongoing · initiated 2025-12-19

Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.

Novo Nordisk Inc.

US Class II Ongoing · initiated 2025-12-19

Presence of Particulate Matter: Hair was found in a prefilled syringe

Novo Nordisk Inc.

US Class II Ongoing · initiated 2025-12-19

Presence of Particulate Matter: Hair was found in a prefilled syringe

Sato Pharmaceutical Co., Ltd

US Class II Ongoing · initiated 2025-12-19

Failed Disintegration Specifications: above the time expected.

Imprimis NJOF, LLC

US Class II Ongoing · initiated 2025-12-18

Presence of particulate matter - Glass like particles.

Imprimis NJOF, LLC

US Class II Ongoing · initiated 2025-12-18

Presence of particulate matter - Glass like particles.

Imprimis NJOF, LLC

US Class II Ongoing · initiated 2025-12-18

Presence of particulate matter - Glass like particles.

Viazen Immunity

Canada Type III Ongoing · initiated 2025-12-18

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

Teva-Topilene Ointment 0.05%

Canada Type II Ongoing · initiated 2025-12-18

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

CareFusion 213, LLC

US Class II Ongoing · initiated 2025-12-17

Lack of Assurance of Sterlity

APO-TRAVOPROST-TIMOP PQ

Canada Type II Ongoing · initiated 2025-12-17

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

SpecGx, LLC

US Class II Ongoing · initiated 2025-12-16

Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

SpecGx, LLC

US Class II Ongoing · initiated 2025-12-16

Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

Alembic Pharmaceuticals Limited

US Class III Ongoing · initiated 2025-12-16

Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

NOVADOZ PHARMACEUTICALS LLC

US Class III Ongoing · initiated 2025-12-15

Failed Impurities/Degradation Specifications

StuffbyNainax

US Class I Ongoing · initiated 2025-12-15

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil

Merck Sharp & Dohme LLC

US Class II Ongoing · initiated 2025-12-12

Presence of particulate matter: potential presence of metal particulates in the product.

Merck Sharp & Dohme LLC

US Class II Ongoing · initiated 2025-12-12

Presence of particulate matter: potential presence of metal particulates in the product.